Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04735666

European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,300 (estimated)
Sponsor
University of Kiel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

University of Schleswig-Holstein Campus Kiel is sponsoring the European TauroPace Registry. This investigator-initiated local, prospective, non-interventional, multi-center study includes patients undergoing cardiac implantable electronic placement including and not limited to placement, revision with the aim to upgrade or downgrade, generator substitution, additional lead placement, revision or extraction (procedure) with adjunct TauroPace. It is planned to include a total of at least 2300 procedures (valid for safety analysis).

Detailed description

This study is performed as an all-case investigation. The treatment is performed based on the SOPs (Appendix Study Protocol). The standard observation period is 3 months from the 1st treatment. Safety and effectiveness are evaluated at 3rd and 12th month. In addition, the extension observation is carried out once a year for 3 years at the longest to collect information on safety and effectiveness as long as CIED treatment continues. When the treatment ends (extraction of all hardware), observation of a patient ends. For each patient, the investigator records data as defined in the protocol at each evaluation point by using a unique Case Report Form (CRF) system. The duration of the study is estimated at 10 years (registry).

Conditions

Interventions

TypeNameDescription
DEVICETauroPace™TauroPace™ is intended to be used as a disinfecting solution during any CIED related surgery procedure or handling of any uncoated or silicon-, epoxy- or polyurethane-coated CIED (including its components, e.g., leads) made of titan or stainless steel in any adult patient requiring or carrying a CIED.

Timeline

Start date
2021-02-22
Primary completion
2030-01-30
Completion
2030-01-30
First posted
2021-02-03
Last updated
2025-04-06

Locations

8 sites across 5 countries: Austria, France, Germany, Italy, United Kingdom

Source: ClinicalTrials.gov record NCT04735666. Inclusion in this directory is not an endorsement.